36 related articles for article (PubMed ID: 8436816)
1. ZBTB32 is an early repressor of the CIITA and MHC class II gene expression during B cell differentiation to plasma cells.
Yoon HS; Scharer CD; Majumder P; Davis CW; Butler R; Zinzow-Kramer W; Skountzou I; Koutsonanos DG; Ahmed R; Boss JM
J Immunol; 2012 Sep; 189(5):2393-403. PubMed ID: 22851713
[TBL] [Abstract][Full Text] [Related]
2. Kinetics of a gamma interferon response: expression and assembly of CIITA promoter IV and inhibition by methylation.
Morris AC; Beresford GW; Mooney MR; Boss JM
Mol Cell Biol; 2002 Jul; 22(13):4781-91. PubMed ID: 12052885
[TBL] [Abstract][Full Text] [Related]
3. Associations and interactions between bare lymphocyte syndrome factors.
DeSandro AM; Nagarajan UM; Boss JM
Mol Cell Biol; 2000 Sep; 20(17):6587-99. PubMed ID: 10938133
[TBL] [Abstract][Full Text] [Related]
4. The MHC class II transactivator (CIITA) requires conserved leucine charged domains for interactions with the conserved W box promoter element.
Brown JA; Rogers EM; Boss JM
Nucleic Acids Res; 1998 Sep; 26(18):4128-36. PubMed ID: 9722631
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the expressed CIITA allele in the class II MHC transcriptional mutant RJ2.2.5.
Brown JA; He XF; Westerheide SD; Boss JM
Immunogenetics; 1996; 43(1-2):88-91. PubMed ID: 8537130
[No Abstract] [Full Text] [Related]
6. Function of major histocompatibility complex class II promoters requires cooperative binding between factors RFX and NF-Y.
Reith W; Siegrist CA; Durand B; Barras E; Mach B
Proc Natl Acad Sci U S A; 1994 Jan; 91(2):554-8. PubMed ID: 8290561
[TBL] [Abstract][Full Text] [Related]
7. Functional complementation of major histocompatibility complex class II regulatory mutants by the purified X-box-binding protein RFX.
Durand B; Kobr M; Reith W; Mach B
Mol Cell Biol; 1994 Oct; 14(10):6839-47. PubMed ID: 7935401
[TBL] [Abstract][Full Text] [Related]
8. Affinity enrichment and functional characterization of TRAX1, a novel transcription activator and X1-sequence-binding protein of HLA-DRA.
Itoh-Lindstrom Y; Peterlin BM; Ting JP
Mol Cell Biol; 1995 Jan; 15(1):282-9. PubMed ID: 7799935
[TBL] [Abstract][Full Text] [Related]
9. Sequencing of an upstream region of the human HLA-DRA gene containing X' and Y' boxes.
Feriotto G; Mischiati C; Bianchi N; Rutigliano C; Giacomini P; Gambari R
Nucleic Acids Res; 1995 May; 23(10):1671-8. PubMed ID: 7784170
[TBL] [Abstract][Full Text] [Related]
10. Definition of a novel complementation group in MHC class II deficiency.
Peijnenburg A; Godthelp B; van Boxel-Dezaire A; van den Elsen PJ
Immunogenetics; 1995; 41(5):287-94. PubMed ID: 7721350
[TBL] [Abstract][Full Text] [Related]
11. Two B cell factors bind the HLA-DRA X box region and recognize different subsets of HLA class II promoters.
Hasegawa SL; Boss JM
Nucleic Acids Res; 1991 Nov; 19(22):6269-76. PubMed ID: 1956787
[TBL] [Abstract][Full Text] [Related]
12. MHC class I and II deficiencies.
Hanna S; Etzioni A
J Allergy Clin Immunol; 2014 Aug; 134(2):269-75. PubMed ID: 25001848
[TBL] [Abstract][Full Text] [Related]
13. Molecular genetics of the Bare lymphocyte syndrome.
Masternak K; Muhlethaler-Mottet A; Villard J; Peretti M; Reith W
Rev Immunogenet; 2000; 2(2):267-82. PubMed ID: 11258423
[TBL] [Abstract][Full Text] [Related]
14. Protease treatment of nuclear extracts distinguishes between class II MHC X1 box DNA-binding proteins in wild-type and class II-deficient B cells.
Hasegawa SL; Riley JL; Sloan JH; Boss JM
J Immunol; 1993 Mar; 150(5):1781-93. PubMed ID: 8436816
[TBL] [Abstract][Full Text] [Related]
15. Class II MHC transcriptional mutants are defective in higher order complex formation.
Riley JL; Boss JM
J Immunol; 1993 Dec; 151(12):6942-53. PubMed ID: 8258702
[TBL] [Abstract][Full Text] [Related]
16. Purified X2 binding protein (X2BP) cooperatively binds the class II MHC X box region in the presence of purified RFX, the X box factor deficient in the bare lymphocyte syndrome.
Moreno CS; Emery P; West JE; Durand B; Reith W; Mach B; Boss JM
J Immunol; 1995 Nov; 155(9):4313-21. PubMed ID: 7594590
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
